U S PHYSICAL THERAPY INC /NV Earnings Per Share Disclosure
|
For the Year Ended
|
||||||||||||
|
December 31, 2025
|
December 31, 2024
|
December 31, 2023
|
||||||||||
|
|
(In thousands, except per share data) | |||||||||||
| Computation of earnings per share - USPH shareholders: | ||||||||||||
|
Net income attributable to USPH shareholders
|
$
|
39,583
|
$
|
31,424
|
$
|
28,239
|
||||||
|
Charges to retained earnings:
|
||||||||||||
|
Revaluation of redeemable non-controlling interest
|
(24,521
|
)
|
(4,964
|
)
|
(13,565
|
)
|
||||||
|
Tax effect at statutory rate (federal and state)
|
6,510
|
1,268
|
3,466
|
|||||||||
|
$
|
21,572
|
$
|
27,728
|
$
|
18,140
|
|||||||
|
Earnings per share (basic and diluted)
|
$
|
1.42
|
$
|
1.84
|
$
|
1.28
|
||||||
| Shares used in computation: |
||||||||||||
|
Basic and diluted earnings per share - weighted-average shares
|
15,175 |
15,064 |
14,188 |
|||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Mar 1, 2021 | |
| 2018 | Mar 18, 2019 | |
| 2017 | Mar 14, 2018 | |
| 2016 | Jun 7, 2017 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.